1 Biologic Drugs Market Overview 1.1 Biologic Drugs Product Scope 1.2 Biologic Drugs Segment by Type 1.2.1 Global Biologic Drugs Sales by Type (2016 & 2021 & 2027) 1.2.2 Humira 1.2.3 Remicade 1.2.4 Rituxan 1.2.5 Enbrel 1.2.6 Lantus 1.2.7 Avastin 1.2.8 Herceptin 1.2.9 Others 1.3 Biologic Drugs Segment by Application 1.3.1 Global Biologic Drugs Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Diabetes 1.3.3 Inflammation 1.3.4 Auto-Immune Diseases 1.3.5 Blood Diseases 1.3.6 Cardiovascular Diseases 1.3.7 Others 1.4 Biologic Drugs Market Estimates and Forecasts (2016-2027) 1.4.1 Global Biologic Drugs Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Biologic Drugs Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Biologic Drugs Price Trends (2016-2027) 2 Biologic Drugs Estimates and Forecasts by Region 2.1 Global Biologic Drugs Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Biologic Drugs Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Biologic Drugs Sales Market Share by Region (2016-2021) 2.2.2 Global Biologic Drugs Revenue Market Share by Region (2016-2021) 2.3 Global Biologic Drugs Market Estimates and Forecasts by Region (2022-2027) 2.3.1 Global Biologic Drugs Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Biologic Drugs Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 North America Biologic Drugs Estimates and Projections (2016-2027) 2.4.2 Europe Biologic Drugs Estimates and Projections (2016-2027) 2.4.3 China Biologic Drugs Estimates and Projections (2016-2027) 2.4.4 Japan Biologic Drugs Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Biologic Drugs Estimates and Projections (2016-2027) 2.4.6 India Biologic Drugs Estimates and Projections (2016-2027) 3 Global Biologic Drugs Competition Landscape by Players 3.1 Global Top Biologic Drugs Players by Sales (2016-2021) 3.2 Global Top Biologic Drugs Players by Revenue (2016-2021) 3.3 Global Biologic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biologic Drugs as of 2020) 3.4 Global Biologic Drugs Average Price by Company (2016-2021) 3.5 Manufacturers Biologic Drugs Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Biologic Drugs Market Size by Type 4.1 Global Biologic Drugs Historic Market Review by Type (2016-2021) 4.1.1 Global Biologic Drugs Sales Market Share by Type (2016-2021) 4.1.2 Global Biologic Drugs Revenue Market Share by Type (2016-2021) 4.1.3 Global Biologic Drugs Price by Type (2016-2021) 4.2 Global Biologic Drugs Market Estimates and Forecasts by Type (2022-2027) 4.2.1 Global Biologic Drugs Sales Forecast by Type (2022-2027) 4.2.2 Global Biologic Drugs Revenue Forecast by Type (2022-2027) 4.2.3 Global Biologic Drugs Price Forecast by Type (2022-2027) 5 Global Biologic Drugs Market Size by Application 5.1 Global Biologic Drugs Historic Market Review by Application (2016-2021) 5.1.1 Global Biologic Drugs Sales Market Share by Application (2016-2021) 5.1.2 Global Biologic Drugs Revenue Market Share by Application (2016-2021) 5.1.3 Global Biologic Drugs Price by Application (2016-2021) 5.2 Global Biologic Drugs Market Estimates and Forecasts by Application (2022-2027) 5.2.1 Global Biologic Drugs Sales Forecast by Application (2022-2027) 5.2.2 Global Biologic Drugs Revenue Forecast by Application (2022-2027) 5.2.3 Global Biologic Drugs Price Forecast by Application (2022-2027) 6 North America Biologic Drugs Market Facts & Figures 6.1 North America Biologic Drugs Sales by Company 6.1.1 North America Biologic Drugs Sales by Company (2016-2021) 6.1.2 North America Biologic Drugs Revenue by Company (2016-2021) 6.2 North America Biologic Drugs Sales Breakdown by Type 6.2.1 North America Biologic Drugs Sales Breakdown by Type (2016-2021) 6.2.2 North America Biologic Drugs Sales Breakdown by Type (2022-2027) 6.3 North America Biologic Drugs Sales Breakdown by Application 6.3.1 North America Biologic Drugs Sales Breakdown by Application (2016-2021) 6.3.2 North America Biologic Drugs Sales Breakdown by Application (2022-2027) 7 Europe Biologic Drugs Market Facts & Figures 7.1 Europe Biologic Drugs Sales by Company 7.1.1 Europe Biologic Drugs Sales by Company (2016-2021) 7.1.2 Europe Biologic Drugs Revenue by Company (2016-2021) 7.2 Europe Biologic Drugs Sales Breakdown by Type 7.2.1 Europe Biologic Drugs Sales Breakdown by Type (2016-2021) 7.2.2 Europe Biologic Drugs Sales Breakdown by Type (2022-2027) 7.3 Europe Biologic Drugs Sales Breakdown by Application 7.3.1 Europe 133 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 133 Sales Breakdown by Application (2022-2027) 8 China Biologic Drugs Market Facts & Figures 8.1 China Biologic Drugs Sales by Company 8.1.1 China Biologic Drugs Sales by Company (2016-2021) 8.1.2 China Biologic Drugs Revenue by Company (2016-2021) 8.2 China Biologic Drugs Sales Breakdown by Type 8.2.1 China Biologic Drugs Sales Breakdown by Type (2016-2021) 8.2.2 China Biologic Drugs Sales Breakdown by Type (2022-2027) 8.3 China Biologic Drugs Sales Breakdown by Application 8.3.1 China 156 Sales Breakdown by Application (2016-2021) 8.3.2 China 156 Sales Breakdown by Application (2022-2027) 9 Japan Biologic Drugs Market Facts & Figures 9.1 Japan Biologic Drugs Sales by Company 9.1.1 Japan Biologic Drugs Sales by Company (2016-2021) 9.1.2 Japan Biologic Drugs Revenue by Company (2016-2021) 9.2 Japan Biologic Drugs Sales Breakdown by Type 9.2.1 Japan Biologic Drugs Sales Breakdown by Type (2016-2021) 9.2.2 Japan Biologic Drugs Sales Breakdown by Type (2022-2027) 9.3 Japan Biologic Drugs Sales Breakdown by Application 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Biologic Drugs Market Facts & Figures 10.1 Southeast Asia Biologic Drugs Sales by Company 10.1.1 Southeast Asia Biologic Drugs Sales by Company (2016-2021) 10.1.2 Southeast Asia Biologic Drugs Revenue by Company (2016-2021) 10.2 Southeast Asia Biologic Drugs Sales Breakdown by Type 10.2.1 Southeast Asia Biologic Drugs Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Biologic Drugs Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Biologic Drugs Sales Breakdown by Application 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027) 11 India Biologic Drugs Market Facts & Figures 11.1 India Biologic Drugs Sales by Company 11.1.1 India Biologic Drugs Sales by Company (2016-2021) 11.1.2 India Biologic Drugs Revenue by Company (2016-2021) 11.2 India Biologic Drugs Sales Breakdown by Type 11.2.1 India Biologic Drugs Sales Breakdown by Type (2016-2021) 11.2.2 India Biologic Drugs Sales Breakdown by Type (2022-2027) 11.3 India Biologic Drugs Sales Breakdown by Application 11.3.1 India Biologic Drugs Sales Breakdown by Application (2016-2021) 11.3.2 India Biologic Drugs Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Biologic Drugs Business 12.1 Roche 12.1.1 Roche Corporation Information 12.1.2 Roche Business Overview 12.1.3 Roche Biologic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Roche Biologic Drugs Products Offered 12.1.5 Roche Recent Development 12.2 Abbott Laboratories 12.2.1 Abbott Laboratories Corporation Information 12.2.2 Abbott Laboratories Business Overview 12.2.3 Abbott Laboratories Biologic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Abbott Laboratories Biologic Drugs Products Offered 12.2.5 Abbott Laboratories Recent Development 12.3 Johnson & Johnson 12.3.1 Johnson & Johnson Corporation Information 12.3.2 Johnson & Johnson Business Overview 12.3.3 Johnson & Johnson Biologic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Johnson & Johnson Biologic Drugs Products Offered 12.3.5 Johnson & Johnson Recent Development 12.4 Merck & Co. 12.4.1 Merck & Co. Corporation Information 12.4.2 Merck & Co. Business Overview 12.4.3 Merck & Co. Biologic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Merck & Co. Biologic Drugs Products Offered 12.4.5 Merck & Co. Recent Development 12.5 Pfizer 12.5.1 Pfizer Corporation Information 12.5.2 Pfizer Business Overview 12.5.3 Pfizer Biologic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Pfizer Biologic Drugs Products Offered 12.5.5 Pfizer Recent Development 12.6 Amgen 12.6.1 Amgen Corporation Information 12.6.2 Amgen Business Overview 12.6.3 Amgen Biologic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Amgen Biologic Drugs Products Offered 12.6.5 Amgen Recent Development 12.7 Sanofi 12.7.1 Sanofi Corporation Information 12.7.2 Sanofi Business Overview 12.7.3 Sanofi Biologic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Sanofi Biologic Drugs Products Offered 12.7.5 Sanofi Recent Development 12.8 Novartis 12.8.1 Novartis Corporation Information 12.8.2 Novartis Business Overview 12.8.3 Novartis Biologic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Novartis Biologic Drugs Products Offered 12.8.5 Novartis Recent Development 12.9 Eli Lilly 12.9.1 Eli Lilly Corporation Information 12.9.2 Eli Lilly Business Overview 12.9.3 Eli Lilly Biologic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Eli Lilly Biologic Drugs Products Offered 12.9.5 Eli Lilly Recent Development 12.10 Amgen 12.10.1 Amgen Corporation Information 12.10.2 Amgen Business Overview 12.10.3 Amgen Biologic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Amgen Biologic Drugs Products Offered 12.10.5 Amgen Recent Development 13 Biologic Drugs Manufacturing Cost Analysis 13.1 Biologic Drugs Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Biologic Drugs 13.4 Biologic Drugs Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Biologic Drugs Distributors List 14.3 Biologic Drugs Customers 15 Market Dynamics 15.1 Biologic Drugs Market Trends 15.2 Biologic Drugs Drivers 15.3 Biologic Drugs Market Challenges 15.4 Biologic Drugs Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Biologic Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Biologic Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Biologic Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Biologic Drugs Sales (K Units) by Region (2016-2021) Table 5. Global Biologic Drugs Sales Market Share by Region (2016-2021) Table 6. Global Biologic Drugs Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Biologic Drugs Revenue Share by Region (2016-2021) Table 8. Global Biologic Drugs Sales (K Units) Forecast by Region (2022-2027) Table 9. Global Biologic Drugs Sales Market Share Forecast by Region (2022-2027) Table 10. Global Biologic Drugs Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Biologic Drugs Revenue Share Forecast by Region (2022-2027) Table 12. Global Biologic Drugs Sales (K Units) of Key Companies (2016-2021) Table 13. Global Biologic Drugs Sales Share by Company (2016-2021) Table 14. Global Biologic Drugs Revenue (US$ Million) by Company (2016-2021) Table 15. Global Biologic Drugs Revenue Share by Company (2016-2021) Table 16. Global Biologic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Drugs as of 2020) Table 17. Global Biologic Drugs Average Price (USD/Unit) of Key Company (2016-2021) Table 18. Manufacturers Biologic Drugs Manufacturing Sites and Area Served Table 19. Manufacturers Biologic Drugs Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Biologic Drugs Sales (K Units) by Type (2016-2021) Table 22. Global Biologic Drugs Sales Share by Type (2016-2021) Table 23. Global Biologic Drugs Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Biologic Drugs Price (USD/Unit) by Type (2016-2021) Table 25. Global Biologic Drugs Sales Share by Type (2022-2027) Table 26. Global Biologic Drugs Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Biologic Drugs Revenue Share by Type (2022-2027) Table 28. Global Biologic Drugs Price (USD/Unit) by Type (2022-2027) Table 29. Global Biologic Drugs Sales (K Units) by Application (2016-2021) Table 30. Global Biologic Drugs Sales Share by Application (2016-2021) Table 31. Global Biologic Drugs Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Biologic Drugs Price (USD/Unit) by Application (2016-2021) Table 33. Global Biologic Drugs Sales (K Units) by Application (2022-2027) Table 34. Global Biologic Drugs Sales Share by Application (2022-2027) Table 35. Global Biologic Drugs Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Biologic Drugs Revenue Share by Application (2022-2027) Table 37. Global Biologic Drugs Price (USD/Unit) by Application (2022-2027) Table 38. North America Biologic Drugs Sales (K Units) by Company (2016-2021) Table 39. North America Biologic Drugs Sales Market Share by Company (2016-2021) Table 40. North America Biologic Drugs Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Biologic Drugs Revenue Market Share by Company (2016-2021) Table 42. North America Biologic Drugs Sales by Type (2016-2021) & (K Units) Table 43. North America Biologic Drugs Sales Market Share by Type (2016-2021) Table 44. North America Biologic Drugs Sales by Type (2022-2027) & (K Units) Table 45. North America Biologic Drugs Sales Market Share by Type (2022-2027) Table 46. North America Biologic Drugs Sales by Application (2016-2021) & (K Units) Table 47. North America Biologic Drugs Sales Market Share by Application (2016-2021) Table 48. North America Biologic Drugs Sales by Application (2022-2027) & (K Units) Table 49. North America Biologic Drugs Sales Market Share by Application (2022-2027) Table 50. Europe Biologic Drugs Sales (K Units) by Company (2016-2021) Table 51. Europe Biologic Drugs Sales Market Share by Company (2016-2021) Table 52. Europe Biologic Drugs Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Biologic Drugs Revenue Market Share by Company (2016-2021) Table 54. Europe Biologic Drugs Sales by Type (2016-2021) & (K Units) Table 55. Europe Biologic Drugs Sales Market Share by Type (2016-2021) Table 56. Europe Biologic Drugs Sales by Type (2022-2027) & (K Units) Table 57. Europe Biologic Drugs Sales Market Share by Type (2022-2027) Table 58. Europe Biologic Drugs Sales by Application (2016-2021) & (K Units) Table 59. Europe Biologic Drugs Sales Market Share by Application (2016-2021) Table 60. Europe Biologic Drugs Sales by Application (2022-2027) & (K Units) Table 61. Europe Biologic Drugs Sales Market Share by Application (2022-2027) Table 62. China Biologic Drugs Sales (K Units) by Company (2016-2021) Table 63. China Biologic Drugs Sales Market Share by Company (2016-2021) Table 64. China Biologic Drugs Revenue by Company (2016-2021) & (US$ Million) Table 65. China Biologic Drugs Revenue Market Share by Company (2016-2021) Table 66. China Biologic Drugs Sales by Type (2016-2021) & (K Units) Table 67. China Biologic Drugs Sales Market Share by Type (2016-2021) Table 68. China Biologic Drugs Sales by Type (2022-2027) & (K Units) Table 69. China Biologic Drugs Sales Market Share by Type (2022-2027) Table 70. China Biologic Drugs Sales by Application (2016-2021) & (K Units) Table 71. China Biologic Drugs Sales Market Share by Application (2016-2021) Table 72. China Biologic Drugs Sales by Application (2022-2027) & (K Units) Table 73. China Biologic Drugs Sales Market Share by Application (2022-2027) Table 74. Japan Biologic Drugs Sales (K Units) by Company (2016-2021) Table 75. Japan Biologic Drugs Sales Market Share by Company (2016-2021) Table 76. Japan Biologic Drugs Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Biologic Drugs Revenue Market Share by Company (2016-2021) Table 78. Japan Biologic Drugs Sales by Type (2016-2021) & (K Units) Table 79. Japan Biologic Drugs Sales Market Share by Type (2016-2021) Table 80. Japan Biologic Drugs Sales by Type (2022-2027) & (K Units) Table 81. Japan Biologic Drugs Sales Market Share by Type (2022-2027) Table 82. Japan Biologic Drugs Sales by Application (2016-2021) & (K Units) Table 83. Japan Biologic Drugs Sales Market Share by Application (2016-2021) Table 84. Japan Biologic Drugs Sales by Application (2022-2027) & (K Units) Table 85. Japan Biologic Drugs Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Biologic Drugs Sales (K Units) by Company (2016-2021) Table 87. Southeast Asia Biologic Drugs Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Biologic Drugs Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Biologic Drugs Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Biologic Drugs Sales by Type (2016-2021) & (K Units) Table 91. Southeast Asia Biologic Drugs Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Biologic Drugs Sales by Type (2022-2027) & (K Units) Table 93. Southeast Asia Biologic Drugs Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Biologic Drugs Sales by Application (2016-2021) & (K Units) Table 95. Southeast Asia Biologic Drugs Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Biologic Drugs Sales by Application (2022-2027) & (K Units) Table 97. Southeast Asia Biologic Drugs Sales Market Share by Application (2022-2027) Table 98. India Biologic Drugs Sales (K Units) by Company (2016-2021) Table 99. India Biologic Drugs Sales Market Share by Company (2016-2021) Table 100. India Biologic Drugs Revenue by Company (2016-2021) & (US$ Million) Table 101. India Biologic Drugs Revenue Market Share by Company (2016-2021) Table 102. India Biologic Drugs Sales by Type (2016-2021) & (K Units) Table 103. India Biologic Drugs Sales Market Share by Type (2016-2021) Table 104. India Biologic Drugs Sales by Type (2022-2027) & (K Units) Table 105. India Biologic Drugs Sales Market Share by Type (2022-2027) Table 106. India Biologic Drugs Sales by Application (2016-2021) & (K Units) Table 107. India Biologic Drugs Sales Market Share by Application (2016-2021) Table 108. India Biologic Drugs Sales by Application (2022-2027) & (K Units) Table 109. India Biologic Drugs Sales Market Share by Application (2022-2027) Table 110. Roche Corporation Information Table 111. Roche Description and Business Overview Table 112. Roche Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 113. Roche Biologic Drugs Product Table 114. Roche Recent Development Table 115. Abbott Laboratories Corporation Information Table 116. Abbott Laboratories Description and Business Overview Table 117. Abbott Laboratories Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 118. Abbott Laboratories Biologic Drugs Product Table 119. Abbott Laboratories Recent Development Table 120. Johnson & Johnson Corporation Information Table 121. Johnson & Johnson Description and Business Overview Table 122. Johnson & Johnson Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 123. Johnson & Johnson Biologic Drugs Product Table 124. Johnson & Johnson Recent Development Table 125. Merck & Co. Corporation Information Table 126. Merck & Co. Description and Business Overview Table 127. Merck & Co. Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 128. Merck & Co. Biologic Drugs Product Table 129. Merck & Co. Recent Development Table 130. Pfizer Corporation Information Table 131. Pfizer Description and Business Overview Table 132. Pfizer Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 133. Pfizer Biologic Drugs Product Table 134. Pfizer Recent Development Table 135. Amgen Corporation Information Table 136. Amgen Description and Business Overview Table 137. Amgen Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 138. Amgen Biologic Drugs Product Table 139. Amgen Recent Development Table 140. Sanofi Corporation Information Table 141. Sanofi Description and Business Overview Table 142. Sanofi Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 143. Sanofi Biologic Drugs Product Table 144. Sanofi Recent Development Table 145. Novartis Corporation Information Table 146. Novartis Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 147. Novartis Description and Business Overview Table 148. Novartis Biologic Drugs Product Table 149. Novartis Recent Development Table 150. Eli Lilly Corporation Information Table 151. Eli Lilly Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 152. Eli Lilly Description and Business Overview Table 153. Eli Lilly Biologic Drugs Product Table 154. Eli Lilly Recent Development Table 155. Amgen Corporation Information Table 156. Amgen Description and Business Overview Table 157. Amgen Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 158. Amgen Biologic Drugs Product Table 159. Amgen Recent Development Table 160. Production Base and Market Concentration Rate of Raw Material Table 161. Key Suppliers of Raw Materials Table 162. Biologic Drugs Distributors List Table 163. Biologic Drugs Customers List Table 164. Biologic Drugs Market Trends Table 165. Biologic Drugs Market Drivers Table 166. Biologic Drugs Market Challenges Table 167. Biologic Drugs Market Restraints Table 168. Research Programs/Design for This Report Table 169. Key Data Information from Secondary Sources Table 170. Key Data Information from Primary Sources List of Figures Figure 1. Biologic Drugs Product Picture Figure 2. Global Biologic Drugs Sales Market Share by Type in 2021 & 2027 Figure 3. Humira Product Picture Figure 4. Remicade Product Picture Figure 5. Rituxan Product Picture Figure 6. Enbrel Product Picture Figure 7. Lantus Product Picture Figure 8. Avastin Product Picture Figure 9. Herceptin Product Picture Figure 10. Others Product Picture Figure 11. Global Biologic Drugs Sales Market Share by Application in 2021 & 2027 Figure 12. Diabetes Examples Figure 13. Inflammation Examples Figure 14. Auto-Immune Diseases Examples Figure 15. Blood Diseases Examples Figure 16. Cardiovascular Diseases Examples Figure 17. Others Examples Figure 18. Global Biologic Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 19. Global Biologic Drugs Sales Growth Rate (2016-2027) & (US$ Million) Figure 20. Global Biologic Drugs Sales (K Units) Growth Rate (2016-2027) Figure 21. Global Biologic Drugs Price Trends Growth Rate (2016-2027) (USD/Unit) Figure 22. Global Biologic Drugs Revenue Market Share by Region: 2016 VS 2021 Figure 23. Global Biologic Drugs Revenue Market Share by Region: 2021 VS 2027 Figure 24. North America Biologic Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 25. North America Biologic Drugs Sales (K Units) Growth Rate (2016-2027) Figure 26. Europe Biologic Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 27. Europe Biologic Drugs Sales (Million USD) Growth Rate (2016-2027) Figure 28. China Biologic Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 29. China Biologic Drugs Sales (Million USD) and Growth Rate (2016-2027) Figure 30. Japan Biologic Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 31. Japan Biologic Drugs Sales (Million USD) Growth Rate (2016-2027) Figure 32. Southeast Asia Biologic Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 33. Southeast Asia Biologic Drugs Sales (Million USD) Growth Rate (2016-2027) Figure 34. India Biologic Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 35. India Biologic Drugs Sales (Million USD) Growth Rate (2016-2027) Figure 36. Global 5 Largest Biologic Drugs Players Market Share by Revenue in Biologic Drugs: 2016 & 2020 Figure 37. Biologic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 38. Global Biologic Drugs Revenue Share by Type (2016-2021) Figure 39. Global Biologic Drugs Revenue Growth Rate by Type in 2016 & 2020 Figure 40. Global Biologic Drugs Revenue Share by Application (2016-2021) Figure 41. Global Biologic Drugs Revenue Growth Rate by Application in 2016 & 2020 Figure 42. North America Biologic Drugs Sales Market Share by Type in 2020 Figure 43. North America Biologic Drugs Sales Market Share by Application in 2020 Figure 44. Europe Biologic Drugs Sales Market Share by Type in 2020 Figure 45. Europe Biologic Drugs Sales Market Share by Application in 2020 Figure 46. China Biologic Drugs Sales Market Share by Type in 2020 Figure 47. China Biologic Drugs Sales Market Share by Application in 2020 Figure 48. Japan Biologic Drugs Sales Market Share by Type in 2020 Figure 49. Japan Biologic Drugs Sales Market Share by Application in 2020 Figure 50. Southeast Asia Biologic Drugs Sales Market Share by Type in 2020 Figure 51. Southeast Asia Biologic Drugs Sales Market Share by Application in 2020 Figure 52. India Biologic Drugs Sales Market Share by Type in 2020 Figure 53. India Biologic Drugs Sales Market Share by Application in 2020 Figure 54. Key Raw Materials Price Trend Figure 55. Manufacturing Cost Structure of Biologic Drugs Figure 56. Manufacturing Process Analysis of Biologic Drugs Figure 57. Biologic Drugs Industrial Chain Analysis Figure 58. Channels of Distribution Figure 59. Distributors Profiles Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed

Roche Abbott Laboratories Johnson & Johnson Merck & Co. Pfizer Amgen Sanofi Novartis Eli Lilly Amgen